In this piece, we explore reasons for creating a separate conversion factor within the MPFS, initially for advanced primary ...

Health Affairs' Rob Lott interviews Tiffany Lemon of Arizona State University on her recent paper exploring the concept of ...

With a Senate vote looming and reports of an impending White House proposal, this article discusses what has transpired in ...

The Antimicrobial Resistance Strategic Coalition is proof that when experts unite around shared goals, they can drive real change, even in the absence of formal government mandates.

We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options.

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics ...

In late August 2025, CMS released Performance Year (PY) 2024 data for the Medicare Shared Savings Program (MSSP). This marked ...

Margolis Center for Health Policy to the pod to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to ...

Benjamin D. Ukert ([email protected]), Texas A&M University, College Station, Texas, and Elevance Health, Indianapolis, Indiana. Theodoros V. Giannouchos, University ...

Data fragmentation and inefficiency are most evident in the quality reporting approach currently used for accountable care organizations by the Centers for Medicare and Medicaid Services—the ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...